Articles and Videos
Pharma Tech Outlook: InMed Introduces THCV Into the Health and Wellness Industry
InMed's THCV will bring ample opportunity to the health sector to scale up in the market. Read full story via Pharma Tech Outlook.
What are cannabinoid analogs?
Cannabinoid analogs are novel cannabinoid compounds that are slightly modified from the naturally occurring cannabinoids in the plant. Since they have a new molecular structure...
The Intersection Between Medical and Health & Wellness: Force For Knowledge Cannabis Symposium Panel Discussion
InMed Pharmaceuticals' Dr. Shane Johnson and Radicle Science’s Dr. Jeff Chen join the Force Family Office's Force For Knowledge Cannabis Symposium: The Intersection Between Medical...
Source: Force Family Office
InMed Pharmaceuticals publicizes new peer-reviewed study
New academic journal spotlights potential for rare cannabinoids to treat skin conditions Read full article via Mugglehead Magazine. Excerpt: Less popular cannabinoids such as tetrahydrocannabivarin...
Benzinga All Access: Guest Speaker Shane Johnson, BayMedica GM
Dr. Shane Johnson, SVP and GM of BayMedica, InMed's subsidiary, joins Benzinga's All Access Conference on June 17, 2022. Dr. Johnson talks about how manufacturing...
Source: Benzinga All Access
Scientific study on the biological activity of rare cannabinoids and their potential role on skin conditions published in peer-reviewed article
A peer-reviewed scientific study entitled “Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes” has been published in the International Journal of Molecular Sciences....
